Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Epilepsia|June 23, 2011
The prevalence of atypical presentations and comorbidities of benign childhood epilepsy with centrotemporal spikesEliel Tovia, Hadassa Goldberg-Stern, Bruria Ben Zeev, et al.
Epilepsia Open|May 9, 2022
FIRDA, refractory epilepsy, and SEEG-guided RF: A case reportNir Getter, Jehuda Sepkuty, Maya Weinstein, et al.
Frontiers in Pharmacology|July 24, 2023
Therapeutic drug monitoring of lacosamide among children: is it helpful?Elkana Kohn, Mirit Lezinger, Sharon Daniel, et al.
Pediatric Neurology|May 29, 2012
Immunoglobulin treatment for severe childhood epilepsyKaren Geva-Dayan, Zamir Shorer, Shay Menascu, et al.
Translational Psychiatry|September 9, 2022
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label studyMicha Hacohen, Orit E Stolar, Matitiahu Berkovitch, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|October 27, 2018
Lacosamide for SCN2A-related intractable neonatal and infantile seizuresHadar Flor-Hirsch, Eli Heyman, Ayelet Livneh, et al.
Pediatric Neurology|August 28, 2014
Thiamine deficiency in infancy: long-term follow-upAviva Mimouni-Bloch, Hadassa Goldberg-Stern, Rachel Strausberg, et al.
Journal of Psychopharmacology (Oxford, England)|July 4, 2025
Evaluating the impact of cannabis oil for autistic children with and without concomitant medications: Insights from an open-label studyNir Treves, Adi Dagan, Elkana Kohn, et al.
Frontiers in Pharmacology|October 17, 2022
Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safetyOrit Stolar, Ariela Hazan, Roni Enten Vissoker, et al.
Pageof 5